Strs Ohio Purchases New Position in Astera Labs, Inc. $ALAB

Strs Ohio purchased a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, HoldingsChannel.com reports. The firm purchased 12,975 shares of the company’s stock, valued at approximately $1,173,000.

Other institutional investors also recently bought and sold shares of the company. Oliver Lagore Vanvalin Investment Group purchased a new position in Astera Labs during the second quarter valued at approximately $29,000. Bernard Wealth Management Corp. purchased a new position in Astera Labs during the second quarter valued at approximately $36,000. GAMMA Investing LLC raised its position in Astera Labs by 55.7% during the first quarter. GAMMA Investing LLC now owns 794 shares of the company’s stock valued at $47,000 after acquiring an additional 284 shares in the last quarter. Harbour Investments Inc. raised its position in Astera Labs by 351.7% during the first quarter. Harbour Investments Inc. now owns 795 shares of the company’s stock valued at $47,000 after acquiring an additional 619 shares in the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. purchased a new position in Astera Labs during the first quarter valued at approximately $48,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

ALAB has been the subject of several recent research reports. Jefferies Financial Group lifted their price target on Astera Labs from $95.00 to $130.00 and gave the company a “buy” rating in a research report on Tuesday, July 22nd. Bank of America began coverage on Astera Labs in a research report on Friday, October 3rd. They issued a “neutral” rating and a $230.00 price objective for the company. Evercore ISI boosted their price objective on Astera Labs from $104.00 to $215.00 and gave the company an “outperform” rating in a research report on Wednesday, August 6th. Morgan Stanley boosted their price objective on Astera Labs from $200.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday. Finally, CICC Research began coverage on Astera Labs in a research report on Friday, August 29th. They issued an “outperform” rating and a $190.00 price objective for the company. Thirteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and a consensus target price of $181.59.

Astera Labs Stock Performance

Shares of ALAB opened at $181.94 on Thursday. Astera Labs, Inc. has a one year low of $47.13 and a one year high of $262.90. The stock has a market capitalization of $30.24 billion, a price-to-earnings ratio of 163.91, a PEG ratio of 4.40 and a beta of 1.37. The stock has a 50 day moving average price of $196.85 and a 200 day moving average price of $139.01.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.39 by $0.10. Astera Labs had a return on equity of 14.21% and a net margin of 27.50%.The firm had revenue of $230.58 million during the quarter, compared to analysts’ expectations of $206.42 million. During the same period in the previous year, the business earned $0.23 earnings per share. The firm’s revenue for the quarter was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Insider Buying and Selling

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total value of $31,708,410.00. Following the completion of the sale, the director directly owned 385,863 shares in the company, valued at $66,858,482.01. This represents a 32.17% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jitendra Mohan sold 91,441 shares of the company’s stock in a transaction on Monday, August 18th. The shares were sold at an average price of $183.51, for a total value of $16,780,337.91. Following the completion of the sale, the chief executive officer owned 2,170,877 shares of the company’s stock, valued at approximately $398,377,638.27. The trade was a 4.04% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 534,480 shares of company stock worth $97,000,380 over the last quarter. Corporate insiders own 12.50% of the company’s stock.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.